swissnex Startup Bootcamps

Empowering Swiss Startups to Internationalize.

Startups


Empowering Swiss Startups to Internationalize

 

swissnex is the launchpad for Swiss startups in the US. Our equity-free startup programs are customized to the needs of entrepreneurs exploring or entering the US market. With over a decade of experience accelerating the international success of companies such as Mindmaze, faceshift, and Ava, we tailor our toolbox sessions to each startup and offer critical business connections. By joining our community of innovators, Swiss startups gain visibility and a home base to succeed in the US.

Twice a year, swissnex brings together promising Swiss Startups for a two week bootcamp with toolbox sessions, fireside chats, special networking events, a demo night, and more. However it is possible to come to swissnex SF year-round, just indicate your preferred dates in the application.

 

 

The next swissnex Startup Bootcamp takes place in Spring 2021 (the date will be announced shortly). Applications are now accepted.
Important: Applying startups need to be in the
Innosuisse coaching program

 


Participants of the virtual October 2020 bootcamp

ASPIVIX | Mathieu HORRAS, Co-founder & CEO | aspivix.com

Every year, more than 80M women worldwide experience pain, bleeding and tissue tear when undergoing common gynecological procedures that require uterus access. This trauma is generated by the Cervical Tenaculum, an instrument with sharp hooks that pinch the cervix to generate traction. ASPIVIX is changing that by developing a next-generation vacuum-based cervical device that delivers the same maneuverability as the tenaculum without the reported patient trauma. This device is ideal to help address unplanned pregnancies, considered one of the most significant global public health issues, by increasing the adoption of Intrauterine Contraceptive Devices (IUD), the most effective reversible contraceptive option available today. ASPIVIX empowers women and makes them free to choose their contraception option without fear. Find them on Facebook, Instagram, Linkedin, Twitter, and YouTube.


Auxivo AG
| Volker Bartenbach, Co-founder & CEO.  Michael Stucky, Co-founder & Chairman. Fabio Gobbo, Business Developer | auxivo.com

Auxivo is a spinoff from ETH Zurich developing the next generation of lightweight exoskeletons to improve workers‘ lives. Follow them on Facebook, Instagram, Linkedin, and Twitter.

JAMIE & I | Antonia Bolla, Founder | jamieandi.shop

Welcome to Your Personal Online Boutique with Sustainable Designers you’ll LOVE! Curated by Jamie, your personal artificially intelligent online stylist who curates your personal online boutique with a curated selection of sustainable designers tailored to your style. Follow them on Instagram, and Linkedin.

MYLEG | Giacomo Valle, Postdoctoral Researcher at ETHZ | p3.snf.ch

MYLEG is a non-invasive sensory feedback to improve Mobility and to promote cognitive prosthesis integration in people with leg amputation.

Neurosoft Bioelectronics | Nicolas Vachicouras, CEO & Karsten Bagger, CBO | neurosoft-bio.com

Neurosoft Bioelectronics develops implantable medical devices to interface with the brain and spinal cord to treat patients suffering from neurological disorders. Our main USP is that we are the only ones to have been able to combine extremely soft materials that match the mechanical properties of the nervous tissues with high-density electrodes. Thanks to these unique features, we can access some locations of the brain that are impossible to reach surgically otherwise. Our preliminary animal data also suggest that our soft electrodes reduce dramatically inflammation when implanted. Follow them on Linkedin and Twitter.

Optimo Medical AG | Harald P. Studer, CEO & Alexander van der Mey, CCO | optimo-medical.com

Optimo Medical AG is specialized in bio-mechanical analyses and simulation of the anterior eye. Since the companies founding in 2015, the team has built a steady reputation as the leading company in virtual trials for the anterior eye segment, and a global technology leader in patient specific astigmatism management. Follow them on Linkedin.

Scailyte | Peter Nestorov, CEO. Stefan Almestrand, Director Corporate Development. Andrius Serva, Business Development Manager. Agnieszka Sitarska, Business Development Associate | scailyte.com

Scailyte uses single cell technologies and AI to discover biomarkers for diseases in oncology and immunology. We have a number of patented biomarker signatures which we currently are developing into clinical diagnostic applications for hospitals and subsequently patients. Follow them on Linkedin.

 


What We Offer

 

 

 


Since 2010, we’ve supported 98 Swiss startups.

We integrate a community of over 400 founders and organizations.

Our startup alumni have a combined valuation of $1.1B, and have created more than 500 jobs.


In the press

A digital bootcamp for seven Swiss startups to explore the US market (Startupticker.ch – May 12, 2020)
A San Francisco startup guide for international entrepreneurs (Podium – August 13, 2019)
swissnex Startup Bootcamp: Off to San Francisco (Startupticker.ch – August 7, 2019)
Go Global: The swissnex Startup Roadshow in Switzerland (Startupticker.ch – May 14, 2019)
swissnex SF on CNN Money Switzerland (CNN – May 6, 2019)


Coaches & Speakers

Organizers

 

  • Franziska Steiner, organizer, swissnexSF
  • Linda Aerne, organizer, swissnexSF

Partners

Swiss Community

Startupticker.ch | The Swiss Startup News channel Startupticker.ch | The Swiss Startup News channel Atom-Feed: News

  • Swiss startups unveil new solutions at CES 2021
    by Startupticker on January 13, 2021 at 3:02 pm

    The annual CES trade fair is a global platform for innovators to showcase and launch new consumer solutions. The Swiss startups, Leman Micro Devices, Biospectal and Typewise have, within this framework, revealed new solutions and product advancements. Mictic announced its move to establish a presence in Southern California.

  • Promising therapy for patients with spinal cord injuries advances to the next stage
    by Startupticker on January 13, 2021 at 12:30 pm

    ONWARD, formerly known as GTX Medical, announced the enrollment of the first patient in a pivotal trial in the U.S. evaluating its ARC Therapy. The pivotal trial, known as Up-LIFT, will assess the safety and effectiveness of ARC Therapy in restoring hand and arm function in people with spinal cord injury.

  • L'Oréal launches "beauty tech" innovation by startup Gjosa
    by Startupticker on January 12, 2021 at 3:24 pm

    The French cosmetics giant L’Oréal has announced the global roll-out of the L’Oréal Water Saver, a sustainable haircare system for the salon and at-home beauty routine developed by Swiss startup, Gjosa. The system is now available in select L’Oréal salons in New York. Global rollout will start 2021.

  • Routemaster Capital to invest in Zug-based Valour
    by Startupticker on January 11, 2021 at 2:10 pm

    Canadian investment company Routemaster Capital Inc. has entered into a binding Letter of Intent to acquire a 20% equity interest in Valour Structured Products, Inc. The deal values Valour at about CHF50 million.

  • Eleven studios join the SwissGames Showcase 2021
    by Startupticker on January 11, 2021 at 10:21 am

    Pro Helvetia has renewed the SwissGames Showcase mentorship programme enabling 11 new studios to join the program. The selected studios will receive tailored mentorship and access to their coaches’ network.